Tower Research Capital (TRC)’s Cullinan Oncology CGEM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.7K	Buy	4,132 +3,226	+356%	+$41.5K	﹤0.01%	2601
2025 Q4	$9.38K	Sell	906 -6,661	-88%	-$60.1K	﹤0.01%	3902
2025 Q3	$44.9K	Sell	7,567 -615	-8%	-$4.5K	﹤0.01%	2614
2025 Q2	$61.6K	Buy	8,182 +2,523	+45%	+$20.3K	﹤0.01%	2791
2025 Q1	$42.8K	Sell	5,659 -3,141	-36%	-$30.1K	﹤0.01%	2329
2024 Q4	$107K	Buy	8,800 +7,079	+411%	+$102K	﹤0.01%	2114
2024 Q3	$28.8K	Sell	1,721 -2,303	-57%	-$40.9K	﹤0.01%	3025
2024 Q2	$70.2K	Buy	4,024 +3,699	+1,138%	+$78.8K	﹤0.01%	2843
2024 Q1	$5.54K	Sell	325 -9,909	-97%	-$153K	﹤0.01%	4529
2023 Q4	$104K	Sell	10,234 -5,156	-34%	-$45.7K	﹤0.01%	2619
2023 Q3	$139K	Buy	15,390 +12,330	+403%	+$128K	﹤0.01%	1723
2023 Q2	$32.9K	Buy	3,060 +858	+39%	+$9.11K	﹤0.01%	2942
2023 Q1	$23K	Buy	2,202 +1,002	+84%	+$11K	﹤0.01%	3275
2022 Q4	$12K	Sell	1,200 -494	-29%	-$6K	﹤0.01%	3690
2022 Q3	$22K	Buy	1,694 +222	+15%	+$2.99K	﹤0.01%	3853
2022 Q2	$19K	Sell	1,472 -3,842	-72%	-$43.6K	﹤0.01%	3835
2022 Q1	$55K	Sell	5,314 -532	-9%	-$7.19K	﹤0.01%	2652
2021 Q4	$90K	Buy	5,846 +5,107	+691%	+$102K	﹤0.01%	2295
2021 Q3	$17K	Sell	739 -26	-3%	-$695	﹤0.01%	3853
2021 Q2	$20K	Sell	765 -55	-7%	-$1.69K	﹤0.01%	3873
2021 Q1	$34K	Buy	+820	New	+$33.3K	﹤0.01%	3442

Other funds holding CGEM